Exploiting tumor cell senescence in anticancer therapy

키워드

참고문헌 (95)

1. Hayflick, L, "The serial cultivation of human diploid cell strains", Exp. Cell. Res, 25, pp.585~621 (1961)
2. Campisi, J., "Replicative senescence: an old lives' tale?", Cell, 84, pp.497~500 (1996)
3. Deng, Y., "Role of telomeres and telomerase in genomic instability, senescence and cancer", Lab. Invest, 87, pp.1071~1076 (2007)
4. Toussaint, O., "Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes", Exp. Gerontol, 35, pp.927~945 (2000)
5. Gorgoulis, V. G., "Oncogene-induced senescence: the bright and dark side of the response", Curr. Opin. Cell. Biol, 22, pp.816~827 (2010)
6. Ben-Porath, I., "The signals and pathways activating cellular senescence", Int. J. Biochem. Cell. Biol, 37, pp.961~976 (2005)
7. Serrano, M., "Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a", Cell, 88, pp.593~602 (1997)
8. Chen, Z., "Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis", Nature, 436, pp.725~730 (2005)
9. Young, A. P., "VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400", Nat. Cell Biol, 10, pp.361~369 (2008)
10. Shamma, A., "Rb Regulates DNA damage response and cellular senescence through E2F-dependent suppression of N-ras isoprenylation", Cancer Cell, 15, pp.255~269 (2009)
11. Suzuki, M., "Stress-induced premature senescence (SIPS)--influence of SIPS on radiotherapy", J. Radiat. Res, 49, pp.105~112 (2008)
12. Gewirtz, D. A., "Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation", Biochem. Pharmacol, 76, pp.947~957 (2008)
13. Davalos, A. R., "Senescent cells as a source of inflammatory factors for tumor progression", Cancer Metastasis. Rev, 29, pp.273~283 (2010)
14. Campisi, J., "Cellular senescence: a link between cancer and age-related degenerative disease?", Semin. Cancer Biol, 21, pp.354~359 (2011)
15. Young, A. R., "SASP reflects senescence", MBO Rep, 10, pp.228~230 (2009)
16. Coppe, J. P., "The senescence-associated secretory phenotype: the dark side of tumor suppression", Annu. Rev. Pathol, 5, pp.99~118 (2010)
17. Campisi, J., "Aging, cellular senescence, and cancer", Annu. Rev. Physiol, 75, pp.685~705 (2013)
18. de Magalhaes, J. P., "How ageing processes influence cancer", Nat. Rev. Cancer, 13, pp.357~365 (2013)
19. Lopez-Otin, C., "The hallmarks of aging", Cell, 153, pp.1194~1217 (2013)
20. Oyama, K., "AKT induces senescence in primary esophageal epithelial cells but is permissive for differentiation as revealed in organotypic culture", Oncogene, 26, pp.2353~2364 (2007)
21. Dhomen, N., "Oncogenic Braf induces melanocyte senescene and melanoma in mice", Cancer Cell, 15, pp.294~303 (2009)
22. Kuilman, T., "The essence of senescence", Genes Dev, 24, pp.2463~2479 (2010)
23. Dimri, G. P., "A biomarker that identifies senescent human cells in culture and in aging skin in vivo", Proc. Natl. Acad. Sci. U. S. A, 92, pp.9363~9367 (1995)
24. Canpo-Trapero, J., "Cellular senescence in oral cancer and precancer and treatment implications: A review", Acta. Oncologica, 47, pp.1464~1474 (2008)
25. Collado, M., "Tumor biology: senescence in premalignant tumors", Nature, 436, pp.642~ (2005)
26. Byun, H. O., "Cathepsin D and eukaryotic translation elongation factor 1 as promising markers of cellular senescence", Cancer Res, 69, pp.4638~4647 (2009)
27. de Magalhaes, J. P., "Meta-analysis of age-related gene expression profiles identifies common signatures of aging", Bioinformatics, 25, pp.875~881 (2009)
28. Mason, D. X., "Molecular signature of oncogenic ras-induced senescence", Oncogene, 23, pp.9238~9246 (2004)
29. Wennmalm, K., "The expression signature of in vitro senescence resembles mouse but not human aging", Genome. Biol, 6, pp.R109~ (2005)
30. Calvanese, V., "The role of epigenetics in aging and age-related diseases", Ageing. Res. Rev, 8, pp.268~276 (2009)
31. Ohtani, N., "Roles and mechanisms of cellular senescence in regulation of tissue homeostasis", Cancer Sci, 104, pp.525~530 (2013)
32. Adams, P. D., "Healing and hurting: molecular mechanisms, functions, and pathologies of cellular senescence", Mol. Cell, 36, pp.2~14 (2009)
33. Chandler, H., "Stressing the cell cycle in senescence and aging", Curr. Opin. Cell Biol, 25, pp.765~771 (2013)
34. Larsson, L. G., "Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence", Semin. Cancer Biol, 21, pp.367~376 (2011)
35. Reinhardt, H. C, "The p53 network: cellular and systemic DNA damage responses in aging and cancer", Trends. Genet, 28, pp.128~136 (2012)
36. Warfel, N. A., "p21WAF1 and tumourigenesis: 20 years after", Curr. Opin. Oncol, 25, pp.52~58 (2013)
37. Roninson, I. B., "Oncogenic functions of tumour suppressor p21(Waf1", Cip1, Cancer Lett, pp.2002, 179[DOI]
38. Carnero, A, "Absence of p21WAF1 cooperates with c-myc in bypassing Ras-induced senescence and enhances oncogenic cooperation", Oncogene, 23, pp.6006~6011 (2004)
39. Groth, A., "Oncogenic Ras induces p19ARF and growth arrest in mouse embryo fibroblasts lacking p21Cip1 and p27Kip1 without activating cyclin D-dependent kinases", J. Biol. Chem, 275, pp.27473~27480 (2000)
40. Pantoja, C, "Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras", Oncogene, 18, pp.4974~4982 (1999)
41. Indovina, P., "Emerging roles of RB family: new defense mechanisms against tumor progression", J. Cell Physiol, 228, pp.525~535 (2013)
42. Kim, W. Y., "The regulation of INK4", ARF in cancer and aging, 2006, pp.127, 265~275
43. Rayess, H., "Cellular senescence and tumor suppressor gene p16", Int. J. Cancer, 130, pp.1715~1725 (2012)
44. Dominguez-Brauer, C., "Tumor suppression by ARF: gatekeeper and caretaker", Cell Cycle, 9, pp.86~89 (2010)
45. Wadhwa, R., "The ARF-p53 senescence pathway in mouse and human cells", Histol. Histopathol, 19, pp.311~316 (2004)
46. Parrinello, S., "Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation", J. Cell Sci, 118, pp.485~496 (2005)
47. Salminen, A., "Emerging role of NF-kappaB signaling in the induction of senescence-associated secretory phenotype (SASP)", Cell Signal, 24, pp.835~845 (2012)
48. Coppe, J. P., "Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence", J. Biol. Chem, 281, pp.29568~29574 (2006)
49. Gosselin, K., "Senescence-associated oxidative DNA damage promotes the generation of neoplastic cells", Cancer Res, 69, pp.7917~7925 (2009)
50. Bavik, C., "The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms", Cancer Res, 66, pp.794~802 (2006)
51. Pazolli, E., "Senescent stromal-derived osteopontin promotes preneoplastic cell growth", Cancer Res, 69, pp.1230~1239 (2009)
52. Sagiv, A., "Immunosurveillance of senescent cells: the bright side of the senescence program", Biogerontology, 14, pp.617~628 (2013)
53. Acosta, J. C., "Control of senescence by CXCR2 and its ligands", Cell Cycle, 7, pp.2956~2959 (2008)
54. Mariotti, M., "Interleukin 1 alpha is a marker of endothelial cellular senescent", Immun. Ageing, 3, pp.4~ (2006)
55. Orjalo, A. V., "Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6", IL-8 cytokine network, 2009, pp.106, 17031~17036
56. Novakova, Z., "Cytokine expression and signaling in drug-induced cellular senescence", Oncogene, 29, pp.273~284 (2010)
57. Coppe, J. P., "Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor", PLoS Biol, 6, pp.2853~2868 (2008)
58. Lopez-Bermejo, A., "Characterization of insulin-like growth factor-binding protein-related proteins (IGFBP-rPs) 1, 2, and 3 in human prostate epithelial cells: potential roles for IGFBP-rP1 and 2 in senescence of the prostatic epithelium", Endocrinology, 141, pp.4072~4080 (2000)
59. Maki, R. G., "Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer", J. Clin. Oncol, 28, pp.4985~4995 (2010)
60. Wang, S., "Characterization of IGFBP-3, PAI-1 and SPARC mRNA expression in senescent fibroblasts", Mech. Ageing. Dev, 92, pp.121~132 (1996)
61. Puche, J. E., "Human conditions of insulin-like growth factor-I (IGF-I) deficiency", J. Transl. Med, 10, pp.224~ (2012)
62. Liu, D., "Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion", Cancer Res, 67, pp.3117~3126 (2007)
63. Tsai, K. K., "Cellular mechanisms for low-dose ionizing radiation- induced perturbation of the breast tissue microenvironment", Cancer Res, 65, pp.6734~6744 (2005)
64. Dass, K., "Evolving role of uPA", uPAR system in human cancers, 2008, pp.34, 122~136
65. Barcellos-Hoff, M. H., "Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells", Cancer Res, 60, pp.1254~1260 (2000)
66. Schadendorf, D., "IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor", J. Immunol, 151, pp.2667~2675 (1993)
67. Norgauer, J., "Expression and growth-promoting function of the IL-8 receptor beta in human melanoma cells", J. Immunol, 156, pp.1132~1137 (1996)
68. Ksiazek, K., "Senescence induces a proangiogenic switch in human peritoneal mesothelial cells", Rejuvenation. Res, 11, pp.681~683 (2008)
69. Hornebeck, W., "Proteolyzed matrix as a template for the regulation of tumor progression", Biomed. Pharmacother, 57, pp.223~230 (2003)
70. Chaturvedi, S, "Extracellular signals in young and aging breast epithelial cells and possible connections to age-associated breast cancer development", Mech. Ageing. Dev, 132, pp.213~219 (2011)
71. Studebaker, A. W., "Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner", Cancer Res, 68, pp.9087~9095 (2008)
72. Laberge, R. M., "Epithelial-mesenchymal transition induced by senescent fibroblasts", Cancer Microenviron, 5, pp.39~44 (2012)
73. Smit, M. A, "Epithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths", Aging (Albany NY), 2, pp.735~741 (2010)
74. Han, N. K., "Secretome analysis of ionizing radiation-induced senescent cancer cells reveals that secreted RKIP plays a critical role in neighboring cell migration", Proteomics, 12, pp.2822~2832 (2012)
75. Xue, W., "Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas", Nature, 445, pp.656~660 (2007)
76. Kang, T. W., "Senescence surveillance of pre-malignant hepatocytes limits liver cancer development", Nature, 479, pp.547~551 (2011)
77. Sica, A., "Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy", Eur. J. Cancer, 42, pp.717~727 (2006)
78. Nardella, C., "Pro-senescence therapy for cancer treatment", Nat. Rev. Cancer, 11, pp.503~511 (2011)
79. Acosta, J. C., "Senescence: a new weapon for cancer therapy", Trends. Cell Biol, 22, pp.211~219 (2012)
80. Ewald, J. A., "Therapy-induced senescence in cancer", J. Natl. Cancer Inst, 102, pp.1536~1546 (2010)
81. Schwarze, S. R., "The identification of senescence- specific genes during the induction of senescence in prostate cancer cells", Neoplasia, 7, pp.816~823 (2005)
82. Rebbaa, A., "The role of histone acetylation versus DNA damage in drug-induced senescence and apoptosis", Cell. Death. Differ, 13, pp.1960~1967 (2006)
83. Nardella, C., "Pro-senescence therapy for cancer treatment", Nature. Rev. Cancer, 11, pp.503~511 (2011)
84. Lee, J. J., "PTEN status switches cell fate between premature senescence and apoptosis in glioma exposed to ionizing radiation", Cell Death. Differ, 18, pp.666~677 (2011)
85. Asai, A., "A novel telomerase template antagonist (GRN163) as a potential anticancer agent", Cancer Res, 63, pp.3931~3939 (2003)
86. Ventura, A., "Restoration of p53 function leads to tumour regression in vivo", Nature, 445, pp.661~665 (2007)
87. Martinkova, E., "alpha5beta1 integrin antagonists reduce chemotherapy- induced premature senescence and facilitate apoptosis in human glioblastoma cells", Int. J. Cancer, 127, pp.1240~1248 (2010)
88. Bykov, V. J., "Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound", Nat. Med, 8, pp.282~288 (2002)
89. Efeyan, A., "Induction of p53-dependent senescence by the MDM2 antagonist nutlin-3a in mouse cells of fibroblast origin", Cancer Res, 67, pp.7350~7357 (2007)
90. Alimonti, A., "A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis", J. Clin. Invest, 120, pp.681~693 (2010)
91. Benanti, J. A., "The normal response to RAS: senescence or transformation?", Cell Cycle, 3, pp.715~717 (2004)
92. Michaloglou, C., "BRAFE600-associated senescence-like cell cycle arrest of human naevi", Nature, 436, pp.720~724 (2005)
93. Delmore, J. E., "BET bromodomain inhibition as a therapeutic strategy to target c-Myc", Cell, 146, pp.904~917 (2011)
94. Lee, J. J., "Prevention of premature senescence requires JNK regulation of Bcl-2 and reactive oxygen species", Oncogene, 29, pp.561~575 (2010)
95. Kim, B. C., "Wig1 prevents cellular senescence by regulating p21 mRNA decay through control of RISC recruitment", EMBO J, 31, pp.4289~4303 (2012)

관련 논문AI추천